Word is Valeant is closing in on its next CEO, and the stock is off like a rocket
If he signs on, Papa will replace controversial CEO Michael Pearson.
Pearson presided over the company during a glorious growth period up until October, when accusations of malfeasance from a short seller combined with government scrutiny over Valeant's pricing practices brought the company to its knees.
After Valeant failed to deliver its annual report in March, the company announced that Pearson would step down.
Papa, needless to say, will have a lot to take on. The WSJ reports that Bill Ackman of Pershing Square Management, a major shareholder of Valeant, led the search for the new CEO.
From WSJ:
Mr. Papa has broad industry experience with pharmaceutical companies such as Perrigo and wholesalers such as Cardinal Health Inc., skills the Valeant board is seeking to help mend fractured relations with payers. Insurers and pharmacy-benefit managers have pulled back on Valeant drugs after steep price increases and revelations about Valeant's ties to a mail-order pharmacy that pushed its expensive drugs.
Valeant's stock is up almost 9% on this news, but analyst notes about the challenges Papa would face are already circulating around the Street. One said that it was, frankly, a "big surprise."
Here's a take from Morgan Stanley [emphasis ours]:
How might Valeant investors push back? Papa has limited experience in leading branded pharmaceutical franchises; note Valeant's Rx business is the one which is struggling the most. His career has largely focused on generic drugs and Consumer products. Separately,although Papa had a very strong track record for much of his tenure at Perrigo (including being on thecover of Barron's March 26, 2012 article "World's Best 30 CEOs."), execution at Perrigo's highest-multiple businesses has been mixed in recent years. Perrigo's core US Consumer (private label) franchise disappointed due to competitive pressures and new product launch delays. And acquisitions of private label baby formula, pet care, and branded consumer (Omega) faced more challenges than expected shortly after being acquired.
For more, head to the WSJ>>
- A couple accidentally shipped their cat in an Amazon return package. It arrived safely 6 days later, hundreds of miles away.
- A centenarian who starts her day with gentle exercise and loves walks shares 5 longevity tips, including staying single
- 2 states where home prices are falling because there are too many houses and not enough buyers
- "To sit and talk in the box...!" Kohli's message to critics as RCB wrecks GT in IPL Match 45
- 7 Nutritious and flavourful tiffin ideas to pack for school
- India's e-commerce market set to skyrocket as the country's digital economy surges to USD 1 Trillion by 2030
- Top 5 places to visit near Rishikesh
- Indian economy remains in bright spot: Ministry of Finance
- JNK India IPO allotment date
- JioCinema New Plans
- Realme Narzo 70 Launched
- Apple Let Loose event
- Elon Musk Apology
- RIL cash flows
- Charlie Munger
- Feedbank IPO allotment
- Tata IPO allotment
- Most generous retirement plans
- Broadcom lays off
- Cibil Score vs Cibil Report
- Birla and Bajaj in top Richest
- Nestle Sept 2023 report
- India Equity Market